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Introduction
cAMP is a ubiquitous second messenger and is responsible for a 
plethora of cellular effects and biological functions (Beavo and 
Brunton, 2002). The generation of cAMP occurs upon ligand 
binding to Gs protein–coupled receptors (GPCRs) and the conse-
quent activation of a family of transmembrane adenylyl cyclases 
(ACs) localized at the plasma membrane (Cooper, 2005). An al-
ternative source of cAMP is the soluble AC, an enzyme that has 
been shown to localize in different subcellular compartments, 
the activity of which is independent of GPCR stimulation and is 
regulated by bicarbonate and calcium ions (Zippin et al., 2003).
cAMP exerts its cellular functions via the activation of 
three different effectors: the cAMP-dependent PKA, cyclic 
  nucleotide-gated ion channels (Biel et al., 1999), and exchange 
proteins directly activated by cAMP (Epac; Bos, 2003). The ac-
tion of cAMP is terminated via its degradation by phosphodies-
terases (PDEs), a large superfamily of enzymes grouped in 11 
families with >40 isoenzyme variants (Soderling and Beavo, 
2000; Francis et al., 2001; Houslay and Adams, 2003; Lugnier, 
2006). Individual PDE enzymes exert specifi  c functional roles 
as a consequence of the unique combination of regulatory mecha-
nisms, intracellular localization, and enzyme kinetics (Houslay 
and Milligan, 1997; Beavo and Brunton, 2002; Baillie et al., 
2005) and play an important role in shaping intracellular gradi-
ents of cAMP (Rich et al., 2001; Zaccolo and Pozzan, 2002; 
Rochais et al., 2004).
The notion of the spatial regulation of cAMP as a means 
of generating specifi  c downstream responses is now well ac-
cepted (Tasken and Aandahl, 2004; Wong and Scott, 2004). 
Such a paradigm is grounded on increasing evidence that 
cAMP/PKA signaling is compartmentalized in discrete subcel-
lular domains in which PKA is anchored to A kinase–anchoring 
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T
here is a growing appreciation that the cyclic ad-
enosine monophosphate (cAMP)–protein kinase A 
(PKA) signaling pathway is organized to form trans-
duction units that function to deliver speciﬁ  c  messages. 
Such organization results in the local activation of PKA 
subsets through the generation of conﬁ  ned intracellular 
gradients of cAMP, but the mechanisms responsible for 
limiting the diffusion of cAMP largely remain to be clari-
ﬁ   ed. In this study, by performing real-time imaging of 
cAMP, we show that prostaglandin 1 stimulation gener-
ates multiple contiguous, intracellular domains with differ-
ent cAMP concentration in human embryonic kidney 293 
cells. By using pharmacological and genetic manipulation 
of phosphodiesterases (PDEs), we demonstrate that com-
partmentalized PDE4B and PDE4D are responsible for 
selectively modulating the concentration of cAMP in in-
dividual subcellular compartments. We propose a model 
whereby compartmentalized PDEs, rather than represent-
ing an enzymatic barrier to cAMP diffusion, act as a sink 
to drain the second messenger from discrete locations, 
resulting in multiple and simultaneous domains with dif-
ferent cAMP concentrations irrespective of their distance 
from the site of cAMP synthesis.
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proteins (AKAPs; Wong and Scott, 2004) in close proximity to 
its specifi  c targets and is activated by restricted pools of cAMP 
(Buxton and Brunton, 1983; Jurevicius and Fischmeister, 1996; 
Zaccolo and Pozzan, 2002; Mongillo et al., 2004; Barnes et al., 
2005; Dodge-Kafka et al., 2005). However, the concept of the 
restricted intracellular diffusion of cAMP contrasts with the ev-
idence that the diffusion rate of this second messenger in the 
cytosol appears to be unrestrained ( 500–700 μm
2s
−1; Bacskai 
et al., 1993; Nikolaev et al., 2004). To explain the paradox of a 
signaling pathway organized in spatially segregated transduc-
tion units, the selective activation of which is committed to a 
freely diffusible second messenger, the hypothesis of either a 
physical or an enzymatic barrier restricting intracellular diffu-
sion of cAMP has been formulated (Rich et al., 2000, 2001; 
Zaccolo et al., 2002; Cooper, 2003; Rochais et al., 2004; 
  Willoughby et al., 2006; for review see Brunton, 2003).
Recently, new methods for monitoring intracellular cAMP 
concentration in single living cells have been developed. One ap-
proach using cyclic nucleotide-gated ion channel–based sensors 
relies on ion infl  ux measurements as a readout of cAMP changes 
near the plasma membrane (Rich et al., 2001). Another approach 
uses fl  uorescence resonance energy transfer (FRET)–based indi-
cators in which cAMP binding to PKA (Zaccolo et al., 2000) or 
Epac (DiPilato et al., 2004; Nikolaev et al., 2004; Ponsioen et al., 
2004) proteins leads to a change in fl  uorescence emission that 
correlates with the intracellular concentration of cAMP. Such op-
tical biosensors allow the detection of cAMP changes with sub-
micrometer resolution in different intracellular compartments.
These new technologies led to the identifi  cation in human 
embryonic kidney (HEK) 293 cells of a subplasma membrane 
compartment showing a larger rise in cAMP concentration in 
response to prostaglandin 1 (PGE1) receptor stimulation as 
compared with the bulk cytosol (Rich et al., 2001; DiPilato et al., 
2004), but the molecular and structural components responsible 
for such compartmentalization largely remain to be defi  ned. 
Here, we set out to study local cAMP dynamics by using 
FRET-based biosensors that are selectively targeted to distinct 
subcellular compartments in HEK293 cells. We found that com-
partmentalized PDEs, rather than acting as barriers to cAMP 
diffusion from the plasma membrane to the bulk cytosol, act as 
a sink that drains cAMP concentration in defi  ned domains by 
locally degrading the second messenger. As a result, intracellu-
lar cAMP concentration is not bound to change along a uniform 
gradient from the plasma membrane to the deep cytosol, but 
multiple contiguous domains with different concentrations of 
cAMP may coexist within the volume of the cell.
Results
Generation of a FRET-based sensor 
for cAMP targeted to the plasma membrane
We recently generated a FRET-based sensor for real-time imag-
ing of cAMP. The sensor, called PKA-GFP, includes the regula-
tory (R) and catalytic (C) subunits of the PKA tagged with the 
CFP and YFP variants of GFP, respectively (Fig. 1 A). When 
overexpressed in HEK293 cells, PKA-GFP shows a uniform 
distribution in the cytosol (Fig. 1 A).
To compare cAMP dynamics in the bulk cytosol and in 
the subplasma membrane compartment, we generated a variant 
of the PKA-GFP sensor that is targeted to the plasma mem-
brane. To this end, we fused to the N terminus of the R subunit a 
short polypeptide (mp) corresponding to the N-terminal target-
ing signal from the Lyn kinase (Resh, 1999). This sequence is 
posttranslationally myristoylated and palmitoylated and targets 
to the plasma membrane (Fig. 1 B). HEK293 cells cotransfected 
with mpR-CFP and C-YFP (mpPKA-GFP) show the predicted 
localization of both the R and C subunits at the plasma  membrane 
(Fig. 1 B). To verify that modifi  cation of the R-CFP sequence 
with the mp peptide does not affect the sensitivity for cAMP, 
we determined activation constant (Ka) values both for PKA-GFP 
and mpPKA-GFP. As shown in Fig. 1 C, Ka values were identi-
cal for the two sensors (Ka = 0.77 μM). Modifi  cation at the 
N terminus of the R subunit does not affect its dynamic interac-
tions with the C subunit, as shown by its complete release 
Figure 1.  The PKA-based sensor for cAMP. (A) Schematic representation 
of the R and C subunits of PKA fused to CFP and YFP, respectively (top), 
and confocal images showing their localization in HEK293 cells coex-
pressing the two subunits of the sensor (bottom). (B) Schematic representa-
tion of the membrane-targeted version of the PKA-based sensor (top) and 
distribution of the two subunits in HEK293 cells (bottom) as detected at 
the confocal microscope. Bars, 10 μm. (C) Apparent activation constants 
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into the cytosol upon cAMP increase and binding to mpR-CFP. 
C-YFP is effectively resequestered to the plasma membrane upon 
cAMP removal (supplemental material and Video 1; available at 
http://www.jcb.org/cgi/content/full/jcb.200605050/DC1).
PGE1 stimulation generates a higher cAMP 
response under the plasma membrane 
as compared with the bulk cytosol
To verify whether GPCR stimulation generates different cAMP 
signals in the subplasma membrane compartment as compared 
with the bulk cytosol, we stimulated HEK293 cells transfected 
with either PKA-GFP or mpPKA-GFP with 10 μM PGE1 and 
measured cAMP-induced FRET changes in the two compart-
ments. As shown in Fig. 2 (A–C), the cAMP response in the 
subplasma membrane compartment was almost twice as large 
as the response in the bulk cytosol (∆R/R0 = 18.6 ± 2.1 [mean 
± SEM; n = 30] vs. 9.6 ± 1.2% [n = 34]; P = 1.4 × 10
−4). 
Furthermore, the time to reach half-maximal response to PGE1 
was almost twice as fast in the subplasma membrane compart-
ment as compared with the bulk cytosol (t1/2 = 58.9 ± 7.3 [n = 
30] and 110.6 ± 12.5 s [n = 34], respectively; P = 1.7 × 10
−3; 
Fig. 2 D). We found that in  50% of the analyzed cells, PGE1 
generated a transient response in both the subplasma membrane 
compartment and the bulk cytosol, with the level of cAMP re-
turning to baseline levels in 5.8 ± 0.84 and 7.6 ± 1.04 min, re-
spectively, after application of the stimulus (Fig. 2 B). In the 
other 50% of the cells, the response reached a plateau value 
and remained sustained for at least 10 min (unpublished data). 
  Application of the nonselective PDE inhibitor isobutyl-methyl-
xanthine (IBMX; 100 μM) in the continuous presence of PGE1 
raised the cAMP level in both compartments, indicating that 
termination of the cAMP response to PGE1 was caused by PDE 
activity. We excluded any overt role for receptor desensitization 
in the termination of the cAMP response to PGE1 based on the 
observation that it is possible to repeatedly stimulate the PGE1 
receptor and obtain comparable rises in intracellular [cAMP] 
(supplemental material and Fig. S1; available at http://www.jcb.
org/cgi/content/full/jcb.200605050/DC1). The application of 
1 μM PGE1 also generated different cAMP levels in the two 
compartments, with a response in the subplasma membrane com-
partment of 8.2 ± 1.5% (n = 34) and of 3.3 ± 0.6% (n = 33) in 
the bulk cytosol (P = 9.5 × 10
−4; Fig. 2 E).
A unimolecular sensor for cAMP conﬁ  rms 
the generation of discrete cAMP domains 
upon PGE1 stimulation
When using the mpPKA-GFP sensor, the binding of cAMP to 
mpR-CFP causes subunit dissociation, releasing the C-YFP 
subunits to diffuse away from the mpRII-CFP FRET partners 
anchored at the plasma membrane. Conversely, when cAMP 
binds to the R-CFP subunits of PKA-GFP in the bulk cytosol, 
the dissociating C-YFP subunits remain in close proximity to 
their cytosolic R-CFP FRET partners. In our experiments, 
FRET changes are measured as CFP intensity/YFP intensity 
(480/545-nm fl  uorescence emission; see FRET imaging section). 
Therefore, as a result of the diffusion of C-YFP away from 
the plasma membrane, the FRET changes measured upon probe 
dissociation in the subplasma membrane compartment may 
result in artifactually larger values being observed than the 
FRET changes measured in the cytosol. To exclude this possi-
bility and confi  rm that the subplasma membrane compartment 
and the cytosolic compartments show a distinct cAMP response 
Figure 2.  The cAMP response to PGE1 is 
higher under the plasma membrane than in 
the bulk cytosol. (A) Wide-ﬁ   eld images of a 
representative HEK293 cell cotransfected with 
R-CFP (top left) and C-YFP (not depicted) and 
with mpR-CFP (bottom left) and C-YFP (not de-
picted). For the same cell, the pseudocolor im-
ages of the 480/545-nm emission ratio before 
(time = 0 s) and after the addition of 10 μM 
PGE1 (time = 200 s) and 100 μM IBMX (time = 
800 s) are shown on the right. Bars, 10 μm. 
(B) Kinetics of cAMP changes recorded in the 
cells shown in A. Open circles represent kinet-
ics recorded in the bulk cytosol with PKA-GFP, 
and closed circles represent kinetics recorded 
at the plasma membrane with mpPKA-GFP. 
(C) Summary of all the experiments performed 
in the same conditions as in A and B. (D) Time 
to reach half-maximal response (t/2) to 10 μM 
PGE1. (E) The summary of experiments per-
formed by applying 1 μM PGE1. Error bars in-
dicate SEM. *, 0.01 < P < 0.05; **, 0.005 
< P < 0.01; ***, P < 0.005.JCB • VOLUME 175 • NUMBER 3 • 2006  444
to PGE1, we used a unimolecular FRET sensor for cAMP based 
on Epac1 (H30; Fig. 3 A). As H30 is a single polypeptide chain, 
CFP and YFP do not diffuse apart upon cAMP binding. We 
modifi  ed H30 by fusing the plasma membrane–targeting mp se-
quence (mpH30; Fig. 3 B) to its N terminus, which, as with RII, 
allowed for the effective targeting of this unimolecular sensor to 
the plasma membrane (Fig. 3 B). Membrane targeting of H30 
did not substantially modify its sensitivity to cAMP, as shown 
by the apparent dissociation constants measured for H30 and 
mpH30 (EC50 = 12.5 and 20 μM, respectively; Fig. 3 C). Using 
these unimolecular probes, we show in Fig. 3 (D and E) that the 
stimulation of HEK293 cells expressing H30 or mpH30 with 
1 μM PGE1 generated a mean ∆R/R0 of 23.5 ± 1.4 (n = 40) and 
31.4 ± 1.2% (n = 36), respectively (P = 10
−4). These results 
confi  rm that PGE1 stimulation generates a compartmentalized 
cAMP response, with a higher level of cAMP being generated 
in the subplasma membrane compartment as compared with the 
bulk cytosol. Interestingly, the steepness of the cAMP gradient 
between the subplasma membrane and bulk cytosol compart-
ments is smaller (35% higher cAMP response at the plasma 
membrane vs. the cytosol) as compared with the steepness of 
the gradient recorded with the PKA-based sensor (148% higher 
cAMP response at the plasma membrane vs. the cytosol; com-
pare Fig. 2 E with Fig. 3 E).
PKA enhances the cAMP gradient 
between the plasma membrane 
and the cytosol via PDE activation
The PKA-based and Epac1-based sensors both clearly reveal 
a gradient of cAMP between the plasma membrane and the 
  cytosol upon PGE1 stimulation. However, such a gradient appears 
steeper when detected by the PKA-GFP probe as compared 
with H30. One possible explanation for this is that overexpres-
sion of the PKA-based sensor, the catalytic subunit of which 
is enzymatically active, may affect the steepness of the cAMP 
gradient. To test this hypothesis, we measured cAMP levels in 
HEK293 cells transfected with either H30 or mpH30 alone or 
in combination with untagged PKA. As shown in Fig. 4 (A and B), 
in the presence of overexpressed PKA, the FRET change 
recorded at the plasma membrane was ∆R/R0 = 9.5 ± 1% 
(n = 48), whereas the FRET change recorded in the bulk cytosol 
was ∆R/R0 = 5.8 ± 0.5% (n = 60; P = 0.0009), indicating 
that the level of cAMP is  62% higher at the plasma mem-
brane as compared with the cytosol. Thus, PKA overexpres-
sion increases the steepness of the cAMP gradient between the 
two compartments around twofold. In further support of this, 
we found that the higher the level of PKA overexpression, 
the larger the effect is on the steepness of the cAMP gradient 
(supplemental material and Fig. S2; available at http://www.jcb.
org/cgi/content/full/jcb.200605050/DC1).
PKA is known to activate PDE3 and PDE4 families of 
PDEs, thereby stimulating the degradation of cAMP (Smith 
et al., 1996; MacKenzie et al., 2002). Interestingly, PDE4 and 
PDE3 are the major cAMP PDE activities represented in 
HEK293 cells, with PDE4 accounting for  68% of the total 
PDE activity and PDE3 accounting for a remaining 30% (Lynch 
et al., 2005). Therefore, we asked whether PDEs may be the 
  effectors of PKA in modulating the steepness of the cAMP 
  gradient. We found that the inhibition of PDEs with 100 μM of 
the nonselective PDE inhibitor IBMX completely abolished the 
Figure 3.  A unimolecular Epac-based sensor detects different [cAMP] at the plasma membrane and in the bulk cytosol. (A) Schematic representation of the 
fusion protein constituting the Epac-based cAMP sensors H30 and confocal micrographs showing its distribution in HEK293 cells. (B) Structure and localiza-
tion of the membrane-targeted version of mpH30. Bars, 10 μm. (C) cAMP dose-response curves measured as the percent FRET changes of H30 (white 
  circles), mpH30 (black circles), and nlsH30 (gray circles). EC50 are 12.5, 20, and 17.5 μM, respectively. (D) Representative kinetics of cAMP changes 
generated in the cytosol (white circles) and at the plasma membrane (black circles) upon stimulation with 1 μM PGE1 followed by 100 μM IBMX. (E) Sum-
mary of the experiments performed as in D. Error bars represent SEM. **, P = 0.002; ***, P = 10
−4.CONTROLLED DIFFUSION OF CAMP • TERRIN ET AL. 445
effect of PKA overexpression on the cAMP gradient (cytosol 
∆R/R0 = 26.03 ± 1.73% [n = 64] in the cytosol and 32.46 ± 
1.72% [n = 56] at the plasma membrane; P = 0.009; Fig. 4 B), 
reestablishing a difference in the cAMP level present in the two 
compartments of  25% (compare Fig. 4 B with Fig. 3 E). These 
results confi  rm that PDEs mediate the effect of PKA on the 
cAMP gradient. In agreement with this fi  nding and in support of 
the key role played by PKA in shaping the cAMP gradient, the 
inhibition of overexpressed PKA activity with 10 μM H89 
completely abolished the cAMP gradient (∆R/R0 = 12.7 ± 
2.05% [n =35] in the cytosol and 16.18 + 2.7% [n =22] at the 
plasma membrane; P = NS; Fig. 4 B). Similarly, the inhibition 
of endogenous PKA with H89 was suffi  cient to completely dis-
sipate the cAMP gradient generated upon PGE1 stimulation 
(Fig. 4 C). Interestingly, the cAMP response to PGE1 in the 
presence of H89 was invariably more sustained in time, with the 
level of cAMP being reduced by only  25% at 10 min after ap-
plication of the stimulus.
To determine the contribution of different PDE families in 
shaping the cAMP gradient, we selectively inhibited either 
PDE4 with 10 μM rolipram (MacKenzie and Houslay, 2000) or 
PDE3 with 10 μM cilostamide (Manganiello and Degerman, 
1999). We found that the sole inhibition of PDE4 reproduced 
the effect of total PDE inhibition with IBMX (∆R/R0 = 30.88 ± 
3.9% [n = 14] in the cytosol and 41.8 ± 2% [n = 16] at the 
plasma membrane; P = 0.01; compare Fig. 5 with Fig. 4 B). 
Rolipram showed a similar effect in cells transfected with H30 
or mpH30 in the absence of overexpressed PKA (unpublished 
data). Conversely, selective PDE3 inhibition with 10 μM cilo-
stamide did not substantially raise the cAMP level generated by 
PGE1 stimulation in either compartments both in the presence 
(∆R/R0 = 5.05 ± 0.6% [n = 16] in the cytosol and 10.8 ± 1.7% 
[n = 12] at the plasma membrane; P = 0.00095; Fig. 5) and in 
the absence of overexpressed PKA (not depicted). These results 
strongly indicate that PDE4 is the key regulator of the intracel-
lular cAMP gradient in HEK293 cells.
Tethered PDEs determine the direction 
of the cAMP gradient in HEK293 cells 
upon PGE1 stimulation
Our results are in agreement with studies indicating that PDEs 
may be responsible for the generation of intracellular cAMP 
gradients by acting as an enzymatic barrier that by rapidly de-
grading cAMP limits its diffusion from the site of synthesis 
(the plasma membrane) to the deep cytosol (Rich et al., 2000; 
  Rochais et al., 2004; Mongillo et al., 2004). According to this 
view, the inhibition of PDE activity would abolish the barrier to 
cAMP diffusion and should result in a fast reequilibration of cAMP 
concentration within the cell. Surprisingly, however, our results 
show that PDE inhibition with either IBMX or rolipram does 
not dissipate the cAMP gradient between the plasma membrane 
and the bulk cytosol elicited by PGE1 stimulation (Figs. 2, B–E; 
3 E, 4, and 5). We reasoned that as both IBMX and rolipram 
are competitive PDE inhibitors, in the high [cAMP] subplasma 
membrane compartment, they may be less effi  cient in inhibiting 
PDEs than in the bulk cytosol (lower [cAMP]), thus sustaining 
the cAMP gradient between the two compartments.
To test the effect of noncompetitive inhibition of PDE4 
on the intracellular cAMP gradient, we performed genetic abla-
tion of PDEs by an RNA silencing approach to reduce enzyme 
concentration. The most represented PDE4 subfamilies in 
HEK293 cells are PDE4B and PDE4D, with PDE4B represent-
ing  30% of the total PDE4 activity and PDE4D representing 
 65% in these cells (Lynch et al., 2005). Therefore, we  focused 
on these two subfamilies. The design of siRNA  oligonucleotides 
Figure 4.  Role of PKA in shaping the cAMP gradient between the plasma 
membrane and the cytosol. (A and B) Representative cAMP kinetic   (Romoser 
et al., 1996) and summary of experiments (B) performed in HEK293 cells 
cotransfected with PKA and either H30 or mpH30 and challenged with 
1 μM PGE1 followed by either total PDE inhibition with 100 μM IBMX or 
PKA inhibition with 10 μM H89 as indicated. (C and D) Representative 
  kinetics (C) and summary of experiments (D) showing the effect of endo-
genous PKA inhibition on the cAMP response induced by 10 nM PGE1 at 
the plasma membrane and bulk cytosol in the absence and presence of the 
PKA inhibitor H89 (10 μM). In all of the experiments, when the PKA inhibi-
tor was used, cells were preincubated for 10 min with H89, and the inhibi-
tor was present throughout the experiment. Error bars represent SEM. 
*, P = 0.02; **, P = 0.009; ***, P = 0.0009.
Figure 5. Identiﬁ  cation of the prevalent PDE affecting the cAMP response 
to PGE1. Summary of the effect of selective PDE3 (10 μM cilostamide) or 
PDE4 (10 μM rolipram) inhibition on the cAMP response in the cytosolic 
(H30) and subplasma membrane (mpH30) compartments upon 1 μM 
PGE1 stimulation of HEK cells overexpressing untagged PKA. Error bars 
represent SEM. *, P = 0.01; ***, P < 0.00095.JCB • VOLUME 175 • NUMBER 3 • 2006  446
as well as the time and means of transfection had been previ-
ously optimized by us to achieve  95% selective knockdown 
of each PDE subfamily in HEK293 cells (Lynch et al., 2005). 
We found that the genetic knockdown of PDE4B did not 
affect the cAMP gradient (∆R/R0 = 13.9 ± 2.2 [n = 27] and 
8.5 ± 1.2% [n = 23] in the subplasma membrane and bulk 
  cytosol, respectively; P = 0.04; Fig. 6 B). Surprisingly, when 
we cotransfected the cAMP sensor with siRNA sequences that 
selectively knock down PDE4D, we found that the cAMP re-
sponse was higher in the cytosol as compared with the 
subplasma membrane compartment (∆R/R0 = 22.8 ± 2.4 [n = 
25] and 14.6 ± 2.5% [n = 23], respectively; P = 0.04; Fig. 6 C). 
The fi  nding that the ablation of PDE4D results in the inver-
sion of the cAMP gradient suggests that a PDE different from 
PDE4D is active in the subplasma membrane compartment and 
maintains the cAMP concentration low in that domain. In fact, 
when we ablated both PDE4B and PDE4D, we found that the 
cAMP gradient was completely abolished (∆R/R0 = 22.8 ± 
2.2% [n = 20] in the cytosol and 20.3 ± 2.4% [n = 22] in 
the subplasma membrane compartment; Fig. 6 D). Overall, our 
  results suggest that PDE4B mainly regulates the subplasma 
membrane compartment, whereas PDE4D mainly regulates the 
cytosolic pool.
The ability of individual PDE4 subfamilies to control 
cAMP concentration independently in defi  ned compartments 
implies that they are selectively tethered within such compart-
ments. To test this, we overexpressed catalytically inactive point 
mutants of PDE4B and PDE4D in HEK293 cells. Such mutants 
have been shown to exert a dominant-negative (dn) effect by 
displacing the cognate endogenous active PDE4 isoforms from 
their functionally relevant anchor sites (Baillie et al., 2003). As 
shown in Fig. 7 A, upon the overexpression of either dnPDE4B1 
or dnPDE4B2, the cAMP response to PGE1 was higher in the 
subplasma membrane compartment than in the cytosol. This 
fi  nding indicates that the displacement of PDE4B from its anchor 
sites and its consequent distribution inside the cell do not affect 
the gradient dictated by the prevalent PDE4D activity localized in 
the cytoplasm. On the contrary, the overexpression of dnPDE4D3 
or dnPDE4D5 completely abolished the cAMP gradient (Fig. 
7 B), as expected upon displacement of the prevalent PDE4D 
activity from its anchor sites within the cytoplasm. Overall, 
these results confi  rm that the different cAMP concentrations in 
these two compartments are dependent on compartmentalized 
PDE4 isoforms.
Figure 6.  Effect of genetic ablation of selected PDEs 
on the cAMP gradient between the plasma membrane 
and bulk cytosol. (A–D) Summary of the effect on the 
cAMP response generated by 1 μM PGE1 either in the 
bulk cytosol (open bars) or at the plasma membrane 
(closed bars) in HEK293 cells expressing either H30 
or mpH30 in control cells (A; Romoser et al., 1996) or 
cells transfected with siRNA oligonucleotides for the 
selective genetic knockdown of PDE4B (B), PDE4D 
(C), or both (D). For each experimental group, n ≥ 25. 
In each panel, the schematics on the right show the 
observed distribution of the cAMP gradient (in red) 
and the predicted distribution of endogenous PDEs upon 
the selective knockdown of speciﬁ  c PDE4 subfamilies. 
As shown, a lower concentration of cAMP corresponds 
to a region with higher PDE4 activity. Error bars repre-
sent SEM. *, P = 0.04; ***, P = 10
−4.
Figure 7.  Effect of the selective displacement of PDE4 subfamilies on the 
cAMP gradient. (A and B) Response to 1 μM PGE1 in HEK293 cells express-
ing the dn variants of PDE4B1 or PDE4B2 (A; Romoser et al., 1996) and 
  expressing the dn variants of PDE4D3 or PDE4D5 (B). For each experimental 
group, n ≥ 17. Schematics on the right of each panel show the observed 
cAMP gradient (in red) and the predicted redistribution of endogenous,   active 
PDE4 subfamilies upon overexpression of the cognate, inactive dn proteins 
(not depicted). Error bars represent SEM. *, P = 0.01; **, P = 0.004.CONTROLLED DIFFUSION OF CAMP • TERRIN ET AL. 447
PDE4B and PDE4D localize in distinct 
compartments in HEK293 cells
The aforementioned effect of the genetic manipulation of 
PDE4B and PDE4D implies a distinct localization of the two 
enzyme subfamilies. To confi  rm this, we performed immuno-
cytochemistry by using monoclonal antibodies specifi  c for either 
subfamilies and found that, as expected, PDE4B shows a preva-
lent localization at the plasma membrane, whereas PDE4D lo-
calizes mainly in the bulk cytosol (Fig. 8). Such membrane 
sequestration of PDE4B is consistent with a previous study 
showing that in HEK293 cells, PDE4B2 is unavailable to inter-
act with cytosolic β-arrestin (Lynch et al., 2005).
PDE4s deﬁ  ne local drains for cAMP 
and generate multiple contiguous, 
intracellular compartments with different 
concentrations of the second messenger
The results presented in Figs. 6 and 7 indicate that PDE4 
enzymes, rather than acting as a barrier to cAMP diffusion 
from the site of synthesis to the bulk cytosol, function as a lo-
cal drain to degrade freely diffusible cAMP and maintain the 
low concentration of the second messenger in discrete com-
partments. Thus, rather than a continuous gradient from the 
plasma   membrane (higher [cAMP]) to the deep cytosol (lower 
[cAMP]), we may expect to fi  nd contiguous compartments with 
higher or lower [cAMP] independent of their distance from the 
site of synthesis but depending on the localization and activity 
of PDEs. According to this hypothesis, a subcellular compart-
ment deeper inside the cell as compared with the bulk cyto-
sol and in which PDE activity is low should show a higher 
[cAMP] as compared with the bulk cytosol. The nucleus is such 
a compartment.
To monitor [cAMP] inside the nucleus, we fused a nuclear 
localization sequence (nls) to the C terminus of the H30 sensor 
(Fig. 9 A) that selectively targets the probe to the nucleus (Fig. 
9 A). When we challenged HEK293 cells transfected with nlsH30 
with 1 μM PGE1, we found that the FRET change was higher in 
the nucleus as compared with the bulk cytosol (∆R/R0 = 28.5 
± 1.7 [n = 25] and 23.5 ± 1.4% [n = 28], respectively; P = 
0.03) and was similar to the FRET change found in the sub-
plasma membrane compartment (Fig. 9, B and C). The different 
response recorded in the nucleus was not caused by a higher 
sensitivity of the nlsH30 sensor to cAMP changes, as indicated 
by similar EC50 (17.5 μM for nlsH30 vs. 12.5 μM for H30; Fig. 
3 C). In apparent contrast with our data showing that there is 
a delay in the cAMP changes in the bulk cytosol as compared 
with the subplasma membrane compartment (Fig. 2 D), the ki-
netics of the nuclear cAMP changes appear to be as fast as those 
occurring at the plasma membrane (Fig. 9 B). This is caused 
by differences in probe kinetics in that the velocity of nlsH30 
FRET change upon [cAMP] rise is signifi  cantly faster than 
the velocity of H30 (P = 0.004) and mpH30 (P = 0.0001) 
FRET changes at the same [cAMP] (supplemental material). 
The difference in the FRET change between the nucleus and the 
bulk cytosol was completely abolished when PDE4D was ab-
lated by siRNA duplex cotransfection (∆R/R0 = 17.7 ± 1.5% 
[n = 26] in the nucleus and 22.8 ± 2.5% [n = 28] in the cytosol; 
Figure 8.  Subcellular localization of PDE4B and PDE4D. Confocal images 
of HEK293 cells stained with monoclonal antibodies speciﬁ   c for either 
PDE4B or PDE4D. The control is the secondary antibody alone. Bars, 10 μm.
Figure 9. PGE1 stimulation generates a larger cAMP response in the 
  nucleus as compared with the bulk cytosol. (A) Schematic representation of 
the sensor H30 targeted to the nucleus (nlsH30) and its distribution in 
HEK293 cells. Bars, 10 μm. (B) Representative kinetics of cAMP changes 
in response to 1 μM PGE1 as detected in the bulk cytosol in cells trans-
fected with H30 (white circles), at the plasma membrane in cells trans-
fected with mpH30 (black circles), and in the nucleus in cells transfected 
with nlsH30 (gray circles). (C) Summary of the experiments performed in 
the aforementioned conditions. (D) Summary of the FRET changes recorded 
in the bulk cytosol (white bar) and in the nucleus (gray bar) of HEK293 
cells cotransfected with either H30 or nlsH30 and siRNA oligonucleotides 
for PDE4D and stimulated with 1 μM PGE1. Error bars represent SEM. **, 
P = 0.03; ***, P = 10
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P = 0.12; Fig. 6 D). These results confi  rm that multiple 
  contiguous, subcellular domains with diverse [cAMP] may co-
exist within HEK293 cells irrespective of their distance from the 
site of cAMP synthesis and depending on PDE4B and PDE4D 
activity and localization.
Discussion
The pleiotropic effects of cAMP pose the pressing question of 
how signaling specifi  city is achieved. In the past few years, 
compartmentalization of the cAMP signal transduction path-
way has emerged as an important mechanism to ensure the nec-
essary specifi  city of response (Tasken and Aandahl, 2004; Wong 
and Scott, 2004). A particular focus has been placed on the or-
ganization of macromolecular complexes, including receptors, 
effectors, modulators, and targets effectively organized in re-
stricted domains, within which the molecular components of 
the complex only affect each other appropriately. Some of these 
domains are localized at the plasma membrane, one example of 
which is the assembly of the β2 adrenergic receptor, heterotri-
meric G proteins, AC, and PKA and its target, the L-type Ca
2+ 
channel Cav1.2 (Davare et al., 2001). Within the complex, acti-
vation of the receptor leads to the synthesis of cAMP and acti-
vation of PKA, which, in turn, can regulate the activity of the 
channel in a highly localized manner. AKAP/PKA signaling do-
mains have also been found to be located deep in the cytosol 
and away from the site of cAMP synthesis, as is the case, for 
example, for the centrosome-associated AKAPs (Witczak et al., 
1999) or the nuclear membrane-associated muscle AKAP 
(Dodge et al., 2001). Specifi  c activation of the PKA pools, 
which are spatially segregated deep inside the cell, requires that 
cAMP is made available selectively in such compartments. How 
the highly hydrophilic, freely diffusible cAMP molecule can 
selectively activate deep intracellular targets without affecting 
PKA enzymes located closer to the site of cAMP synthesis 
  remains to be defi  ned.
One example of the limited diffusion of cAMP is the gen-
eration of a subplasma membrane pool of the second messenger 
in response to PGE1 stimulation of HEK293 cells. To explain 
such compartmentalization, the hypothesis was formulated of a 
physical barrier that is possibly formed by elements of the en-
doplasmic reticulum and localizes underneath the plasma mem-
brane, thereby limiting cAMP diffusion from the site of synthesis 
to the deep cytosol (Rich et al., 2000). However, an important 
contribution to cAMP compartmentalization appears to derive 
from the activity of PDEs, as pointed out by a large body of in-
direct evidence based on altered cell functioning after selective 
PDE inhibition (Rich et al., 2001; Zaccolo and Pozzan, 2002; 
Jurevicius et al., 2003; Abrahamsen et al., 2004; Mongillo et al., 
2004, 2006). PDEs can be targeted to subcellular compartments, 
including the plasma membrane, and can be recruited into multi-
protein signaling complexes (Perry et al., 2002), thereby pro-
viding a means to terminate the cAMP signal in a spatially 
restricted manner (Baillie et al., 2005). Such features suggested 
a role for PDEs as an enzymatic barrier to cAMP diffusion 
(for review see Brunton, 2003; Barnes et al., 2005; Willoughby 
et al., 2006).
The model of a barrier to cAMP diffusion implies the gen-
eration of a gradient of cAMP with a higher concentration of the 
second messenger at the plasma membrane and a progressively 
lower concentration toward the deep cytosol. However, the di-
rection of such a gradient is incompatible with the selective ac-
tivation of a subset of PKA anchored deep inside the cytosol 
without concomitant activation of those PKA enzymes that are 
localized at the plasma membrane and closer to the site of 
cAMP synthesis.
In this study, we set out to study the cAMP response to 
GPCR stimulation of the transmembrane AC with PGE1 in 
HEK293 cells with the aim of defi  ning the role of PDEs in the 
generation of a subplasma membrane pool of high cAMP. We 
applied an imaging approach for real-time monitoring of cAMP 
dynamics in single living cells and used FRET-based biosensors 
selectively targeted to different subcellular domains. We found 
that the cAMP response in the subplasma membrane compart-
ment is higher as compared with the bulk cytosol because of a 
compartmentalized PDE4D located in the cytosol that keeps the 
level of the second messenger low in this compartment. Indeed, 
genetic ablation of PDE4D inverted the direction of the cAMP 
gradient, resulting in a higher concentration of the second mes-
senger in the cytosol as compared with the subplasma mem-
brane compartment. On the contrary, genetic ablation of PDE4B 
did not affect the direction of the gradient. The cAMP gradient 
was completely abolished only when the expression of both 
PDE4B and PDE4D was blocked. These results demonstrate 
that the concerted activity of PDE4B and PDE4D is suffi  cient to 
generate an intracellular cAMP gradient in response to PGE1 in 
HEK293 cells. We also found that dislocation of PDE4D from 
its anchoring sites by means of the overexpression of catalyti-
cally inactive enzymes dissipated the cAMP gradient, indicat-
ing that the compartmentalization of PDE4D is responsible for 
shaping such a gradient.
Intriguingly, we found that the inhibition of endogenous 
PKA with H89 completely abolished the cAMP gradient be-
tween the plasma membrane and bulk cytosol. On the contrary, 
the overexpression of PKA via PDE activation increased the 
steepness of the subplasma membrane cAMP gradient gener-
ated by PGE1. These results indicate that PKA not only has a 
role in shaping the intracellular cAMP gradient upon receptor 
stimulation but also that PKA itself can reinforce the boundar-
ies between the intracellular cAMP compartments and can self-
regulate the specifi  city of its own activity.
In this study, we show for the fi  rst time that a compart-
ment deep inside the cell may accumulate higher levels of 
cAMP as compared with the bulk cytosol. These fi  ndings dem-
onstrate that multiple and contiguous domains with different 
concentrations of cAMP can be generated simultaneously in-
side the cell irrespective of their distance from the site of syn-
thesis of the second messenger. To explain such fi  ndings, we 
must assume that PDEs, rather than acting as enzymatic barriers 
to cAMP diffusion from the plasma membrane to the bulk cyto-
sol, are organized to generate local drains that dump cAMP in 
defi  ned compartments. Such a mechanism of control of cAMP 
diffusion may be more general and may also apply to the pro-
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to soluble AC activation. Therefore, we propose a new model 
whereby cAMP is free to diffuse from the site of synthesis and 
to accumulate in the cell to levels effective for PKA activation 
except in those domains in which localized PDEs degrade it to 
protect sensitive targets from inappropriate activation.
Materials and methods
Reagents
DME, Opti-MEM, FBS, L-glutamine, penicillin, trypsin/EDTA, PBS, and Lipo-
fectAMINE 2000 were purchased from Invitrogen. PGE1 and IBMX were 
obtained from Sigma-Aldrich. Restriction enzymes, T4 ligase, and shrimp 
AP were purchased from New England Biolabs, Inc. FuGENE-6 transfec-
tion reagent was obtained from Roche.
Construct generation
The membrane-targeted version of the R-CFP subunit of the PKA-based 
cAMP sensor (Lissandron et al., 2005) was generated by inserting the N-
terminal targeting signal M  G  C  I  K  S  K  R  K  D  N  L  N  D  D   (mp) from Lyn kinase at the 
N terminus of R-CFP. This becomes posttranslationally myristoylated and 
palmitoylated, resulting in its targeting to membrane rafts. The cAMP 
Epac1-based sensor, called H30, was provided by K. Jalink (The Nether-
lands Cancer Institute, Amsterdam, Netherlands) and corresponds to the 
CFP-Epac(δDEP-CD)-YFP sensor (Ponsioen et al., 2004). The membrane-
  targeted version of H30 was generated by fusion at the N terminus of the 
M  G  C  I  K  S  K  R  K  D  N  L  N  D  D   plasma membrane–targeting sequence. The   nuclear-
targeted version of H30 was generated by fusion of the nuclear   localization 
signal P  K  K  K  R  K  V  E  D  A   (nls) at the C terminus (DiPilato et al., 2004).
Untagged PKA was generated by cloning both the RIIβ subunit of 
PKA and the Cα subunit of PKA into pCDNA3.1 (Invitrogen). Constructs for 
the expression of PKA subunits in Escherichia coli were generated by clon-
ing RIIβ, mpRIIβ, and Cα into pRSETB (Invitrogen).
Activation constants and apparent dissociation constants determination
To determine apparent activation constants for PKA-GFP and mpPKA-GFP, 
the pRSETB vectors carrying the RIIβ, mpRIIβ, or Cα subunits were intro-
duced into BL21(DE3) (Stratagene) for heterologous protein expression in 
bacteria. Individual subunits were subsequently puriﬁ  ed with Ni–nitrilotri-
acetic acid resin according to the manufacturer’s instructions (QIAGEN). 
Puriﬁ  ed proteins were buffer changed by gel ﬁ  ltration to 20 mM MOPS, 
150 mM NaCl, 5 mM MgCl2, 100 μM ATP, and 1 mM β-mercaptoethanol, 
pH 7.0 (dialysis buffer), to remove imidazole. For PKA holoenzyme forma-
tion, PKA-R (PKA-GFP and mpPKA-GFP) and PKA Cα subunits (Slice et al., 
1989; Herberg et al., 1993) were mixed in a molar ratio of 1.5:1.0, 
and dialysis was performed overnight with three buffer changes against 
dialysis buffer (Herberg et al., 1993). For the determination of   activation 
constants, a coupled spectrophotometric assay (Cook et al., 1982) was per-
formed using the peptide kemptide (LRRASLG; Biosynthan) as the   substrate. 
Phosphotransferase activity was measured in an assay mixture consisting 
of 100 mM MOPS, pH 7.0, 10 mM MgCl2, 1 mM phosphoenol pyruvate, 
1 mM ATP, 200 μM NADH, 1 mM DTT, 15 U/ml lactate dehydrogenase 
(Roche), and 70 U/ml pyruvate kinase (Roche). For the reaction, 100 μl 
of assay mixture, 20 nM PKA holoenzyme, and 1 μl kemptide peptide 
(200 μM) were mixed in a quartz cuvette. The enzymatic activity (∆E340nm × 
min
−1) was monitored at room temperature using a spectrophotometer 
(Lambda Bio UV/Vis; PerkinElmer). EC50 values for activation were deter-
mined by preincubating the PKA holoenzyme with increasing concentra-
tions of cAMP for 1 min in assay mixture before starting the reaction with 
kemptide peptide. Data points were determined in duplicates, and experi-
ments were repeated at least twice with similar results. Statistical analyses 
were performed using Prism 4.0 software (GraphPad Software).
To determine in vivo apparent dissociation constants for H30, 
mpH30, and nlsH30, HeLa cells expressing the cAMP sensor were injected 
with known concentrations of cAMP via a patch pipette, and FRET changes 
were recorded as described in the FRET imaging section. Cells were con-
tinuously superfused at 2 ml/min in a standard extracellular solution, ECS-1, 
which contained 150 mM NaCl, 5 mM KCl, 1 mM MgCl2, 10 mM Hepes, 
2 mM CaCl2, 2 mM pyruvate, and 5 mM glucose, pH 7.4. Patch pipettes 
were ﬁ   lled with an intracellular solution, ICS-1, containing 120 mM K-
aspartate, 10 mM TEA-Cl, 1 mM MgCl2, 10 mM Hepes, 10 mM CsCl, 
0.3 mM GTP-Na, 3 mM ATP-K (adjusted to pH 7.2 with KOH), 5 mM 
BAPTA, 1 mM thapsigargin, 0.1 mM IBMX, and 0.007–0.18 mM cAMP 
as indicated and ﬁ   ltered through 0.22-μm pores (Millipore). Only cells 
that displayed a seal resistance of >2 GΩ before achieving the whole cell 
conﬁ  guration were retained. Cells admitted to the analysis after achieving 
the whole cell conﬁ  guration were further characterized by an access resis-
tance of <12 MΩ and an apparent membrane resistance of >300MΩ. 
At least six cells were analyzed for each concentration of cAMP.
Cell culture and transfection
HEK293 cells were grown in DME containing 10% FBS supplemented with 
2 mM L-glutamine, 100 U/ml penicillin, and 100 μg/ml streptomycin in a 
humidiﬁ  ed atmosphere containing 5% CO2. For transient expression, cells 
were seeded onto 24-mm diameter round glass coverslips, and transfec-
tions were performed at 50–70% conﬂ  uence with FuGENE-6 transfection 
reagent according to the manufacturer’s instructions using 1–2 μg DNA 
per coverslip. Imaging experiments were performed after 24–48 h.
To achieve the selective knockdown of PDE4B or PDE4D subfami-
lies, we used double-stranded 21-mer RNA duplexes (Dharmacon) tar-
geted at regions of sequence that are unique to each of these subfamilies 
as described previously (Lynch et al., 2005). Each siRNA duplex was de-
livered into target cells via the reagent LipofectAMINE 2000 (Invitrogen). 
Speciﬁ  cally, 5 μl LipofectAMINE 2000 (1 mg/ml) was diluted in 100 μl 
Opti-MEM, and, separately, 125 pmol of each siRNA sample and 1 μg 
cAMP sensor DNA were diluted in 100 μl Opti-MEM. 200 μl siRNA–DNA 
transfection complexes were added to each well, and the plates were 
  incubated for 3–4 h at 37°C (5% CO2). These complexes were then 
  removed and replaced with DME. Imaging experiments were performed 
after 48 h.
FRET imaging
FRET imaging experiments were performed 24–48 h after transfection. 
Cells were maintained in Hepes-buffered Ringer-modiﬁ  ed saline containing 
125 mM NaCl, 5 mM KCl, 1 mM Na3PO4, 1 mM MgS04, 5.5 mM glu-
cose, 1 mM CaCl2, and 20 mM Hepes, pH 7.5, at room temperature (20–
22°C) and imaged on an inverted microscope (IX50; Olympus) with a 
60× NA 1.4 oil immersion objective (Olympus). The microscope was 
equipped with a CCD camera (Sensicam QE; PCO), a software-controlled 
monochromator (Polychrome IV; TILL Photonics), and a beam-splitter optical 
device (Multispec Microimager; Optical Insights). Images were acquired 
using custom-made software and processed using ImageJ (National Insti-
tutes of Health). FRET changes were measured as changes in the back-
ground-subtracted 480/545-nm ﬂ   uorescence emission intensities on 
excitation at 430 nm and expressed as either R/R0, where R is the ratio at 
time t and R0 is the ratio at time = 0 s, or ∆R/R0, where ∆R = R – R0.
Confocal imaging
Cells were stained with anti-PDE4B and -PDE4D monoclonal antibodies 
(FabGennix). AlexaFluor488-conjugated anti–mouse antibody was used 
as the secondary antibody. Confocal images were acquired with an in-
verted microscope (Eclipse TE300; Nikon) equipped with a spinning disk 
confocal system (Ultraview LCI; PerkinElmer) and a 12-bit CCD camera 
(Hamamatsu; Orca ER). Cells were excited using the 488-nm line of a 
krypton-argon laser (643-Ryb-A02; Melles Griot) for imaging YFP and the 
AlexaFluor488 ﬂ  uorophore and using the 405-nm diode laser (iFlex2000; 
Point Source) for imaging CFP.
Online supplemental material
Fig. S1 shows an evaluation of PGE1 receptor desensitization. Fig. S2 
shows an evaluation of the dose-response relationship between PKA 
overexpression and the steepness of the cAMP gradient. Video 1 shows 
the dynamics interactions between mpRII-CFP and C-YFP upon cAMP 
binding and release. Supplemental material also provides information 
about determination of the velocity of FRET change for the cAMP sensors. 
Online supplemental material is available at http://www.jcb.org/cgi/
content/full/jcb.200605050/DC1.
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